How Novo Nordisk plays its ‘Ace’ in China's ‘Weight Management Year’
As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...
NJ-based Novartis to lay off 427 as drug patent expires
Novartis has over 3,000 employees working at its campus in East Hanover, and 12,000 employees nationwide, said Novartis spokesperson Michael Meo. The 427 layoffs will go into effect between June 13 ...
Novo Nordisk Foundation’s obesity head works as paid adviser to chocolate maker Ferrero
Professor Arne Astrup is also involved in project to change widely-accepted definition of ultra-processed food ...
Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...
The Baltimore Sun16d
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for ... Hopkins to lay off over 200 employees in May as first wave of cuts ...
Lost Money on Novo Nordisk A/S (NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a ...
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Novo Nordisk membership in UK pharma body restored after suspension
Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...
Morningstar3d
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
CASE DETAILS: According to the complaint, on December 20, 2024, Novo issued a press release ... securities litigation and a team of over 70 employees to serve our clients. For seven years in ...
NBC DFW11d
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop ...
ETF Daily News6d
Novo Nordisk A/S (NYSE:NVO) Upgraded at Kepler Capital Markets
Park Square Financial Group LLC bought a new position in shares of Novo Nordisk A/S during the 4th quarter valued at about $29,000. Finally, Employees Retirement System of Texas grew its position ...